The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  2005-03-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00228-005-0896-7PMID 15776276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid

  2004influential reference
• Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage

  2002influential reference
• Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial

  2002cited by this paper
• Erythropoietic agents as neurotherapeutic agents: what barriers exist?

  2002cited by this paper
• Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly

  2001cited by this paper
• Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain

  2001cited by this paper
• Erythropoietin gene expression in different areas of the developing human central nervous system.

  2000cited by this paper
• Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

  2000cited by this paper
• Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration.

  2000cited by this paper
• Lysozyme among the Lilliputians.

  2000cited by this paper
• A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice

  1999cited by this paper
• Effects of Erythropoietin on Neuronal Activity

  1999cited by this paper
• Erythropoietin in the Cerebrospinal Fluid of Neonates Who Sustained CNS Injury

  1999cited by this paper
• In vivo evidence that erythropoietin protects neurons from ischemic damage.

  1998cited by this paper
• The safety of treatment with recombinant human erythropoietin in clinical use: a review of controlled studies.

  1998cited by this paper
• Erythropoietin and Erythropoietin Receptor in the Developing Human Central Nervous System

  1998cited by this paper
• Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery.

  1998cited by this paper
• Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death.

  1996cited by this paper
• Erythropoietin Gene Expression in Human, Monkey and Murine Brain

  1996cited by this paper
• Localization of specific erythropoietin binding sites in defined areas of the mouse brain.

  1995cited by this paper
• A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes.

  1994cited by this paper
• Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers.

  1990influential reference
• Effect of Dexamethasone on Transport of α‐Aminoisobutyric Acid and Sucrose Across the Blood‐Brain Barrier

  1988cited by this paper
• Effect of dexamethasone on blood‐brain barrier in the normal mouse

  1986cited by this paper
• Blood-brain barrier: endogenous modulation by adrenal-cortical function.

  1985cited by this paper

• Prospects of pharmacological regulation of physiological adaptation mechanisms in cerebrovascular insufficiency

  2025cites this paper
• Chronic Administration of Recombinant Human Erythropoietin Induces Angiogenesis in Healthy Mouse Brain

  2024cites this paper
• Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment

  2023cites this paper
• Association of Endogenous Erythropoietin Levels and Iron Status With Cognitive Functioning in the General Population

  2022cites this paper
• Drug Repositioning in Friedreich Ataxia

  2022cites this paper
• Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use

  2022cites this paper
• Cytoprotective effects of erythropoietin: What about the lung?

  2021cites this paper
• Stroke Treatment: Focus on Neuroprotection and EPO

  2021cites this paper
• Detection of a non-erythropoietic EPO, Neuro-EPO, in blood after intra-nasal administration in rat.

  2020cites this paper
• Neuroprotective mechanisms of erythropoietin in a rat stroke model

  2020cites this paper
• A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

  2020cites this paper
• Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?

  2020cites this paper
• Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology.

  2019cites this paper
• How Near Are We to Using Darbepoetin or Erythropoietin as Neuroprotective Agents for Perinatal Hypoxic-Ischemic Encephalopathy?

  2019cites this paper
• Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?

  2019cites this paper
• Time to reconsider extended erythropoietin treatment for infantile traumatic brain injury?

  2019cites this paper
• Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury

  2018cites this paper
• No evidence for direct effects of recombinant human erythropoietin on cerebral blood flow and metabolism in healthy humans.

  2018cites this paper
• 99m Tc-labeled rHuEpo for imaging of the erythropoietin receptor in tumors.

  2018cites this paper
• High-Dose Erythropoietin Population Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia

  2017cites this paper
• Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study

  2017cites this paper
• Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology

  2017cites this paper
• Effects of low-dose recombinant human erythropoietin treatment on cognitive performance.

  2017cites this paper
• Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension

  2017cites this paper
• Erythropoietin Promotes Glioblastoma via miR-451 Suppression.

  2017cites this paper
• Carbamylated erythropoietin enhances mice ventilatory responses to changes in O2 but not CO2 levels.

  2016cites this paper
• Therapies negating neuroinflammation after brain trauma.

  2016cites this paper
• Polycythemia and high levels of erythropoietin in blood and brain blunt the hypercapnic ventilatory response in adult mice.

  2016cites this paper
• EPOhr: FARMACOCINÉTICA, FARMACODINAMIA Y BIODISTRIBUCIÓN EN CONEJOS NUEVA ZELANDA / EPOhr: PHARMACOKINETICS, PHARMACODYNAMICS AND BIODISTRIBUTION IN NEW ZELAND RABBITS

  2015cites this paper
• Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

  2015cites this paper
• Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy

  2015cites this paper
• Erythropoietin: a novel therapy for hypoxic–ischaemic encephalopathy?

  2015cites this paper
• Agonists of the tissue-protective erythropoietin receptor in the treatment of Parkinson's disease.

  2015cites this paper
• Erythropoietin attenuates loss of potassium chloride co-transporters following prenatal brain injury.

  2014cites this paper
• Erythropoietin Improved Cognitive Function and Decreased Hippocampal Caspase Activity in Rat Pups after Traumatic Brain Injury

  2014cites this paper
• Erythropoietin improves neurobehavior by reducing dopaminergic neuron loss in a 6-hydroxydopamine-induced rat model

  2014cites this paper
• НЕЙРОПРОТЕКТИВНЫЕ ЭФФЕКТЫ ЭРИТРОПОЭТИНА: ВОЗМОЖНОСТИ, ПЕРСПЕКТИВЫ И РЕАЛЬНОСТЬ (ОБЗОР ЛИТЕРАТУРЫ)

  2014cites this paper
• Erythropoietin neuroprotection is enhanced by direct cortical application following subdural blood evacuation in a rat model of acute subdural hematoma.

  2013cites this paper
• Influence of Erythropoietin on Cognitive Performance during Experimental Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Randomized Cross-Over Trial

  2013cites this paper
• Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives

  2013cites this paper
• Effects of estrogen in an aged animal model of stroke

  2013cites this paper
• Identification of a therapeutic dose of continuously delivered erythropoietin in the eye using an inducible promoter system.

  2013cites this paper
• Quelles potentialités thérapeutiques pour l’érythropoiétine recombinante dans le traitement des traumatismes du système nerveux central ?

  2012cites this paper
• The role of erythropoietin in the "stroke belt" phenomenon.

  2012cites this paper
• UC San Francisco UC San Francisco Previously Published Works Title Erythropoietin for neuroprotection in neonatal encephalopathy : Safety and pharmacokinetics

  2012cites this paper
• Optimization of anemia management in preterm infants

  2012cites this paper
• Erythropoietin in Brain Development and Beyond

  2012cites this paper
• Erythropoietin for Neuroprotection in Neonatal Encephalopathy: Safety and Pharmacokinetics

  2012cites this paper
• Systemic and renal haemodynamic changes in renal schemia/reperfusion injury: impact of erythropoietin.

  2012cites this paper
• Erythropoietin and the sex-dimorphic chemoreflex pathway.

  2012cites this paper
• Erythropoietin and its antagonist regulate hypoxic fictive breathing in newborn mice.

  2012cites this paper
• TNF and EPO: major players in the innate immune response: their discovery

  2012cites this paper
• Neuroprotective effect of erythropoietin-loaded composite microspheres on retinal ganglion cells in rats.

  2011cites this paper
• The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression

  2011cites this paper
• Systemic AAV-mediated gene therapy using Epo-R76E to protect retinal ganglion cells from optic nerve injury and disease

  2011cites this paper
• The potential role of erythropoietin as a pleiotropic agent in post-cardiac arrest syndrome.

  2011cites this paper
• Intranasal erythropoietin therapy in nervous system disorders

  2011cites this paper
• Systemic Gene Delivery Protects the Photoreceptors in the Retinal Degeneration Slow Mouse

  2011cites this paper
• An investigation of EPO as a tissue protective agent in human kidney transplantation

  2011cites this paper
• Die protektive Wirkung von Erythropoietin in einem Neurodegenerationsmodell der neonatalen Ratte nach Hyperoxie Exposition

  2011cites this paper
• Alterations of mitochondrial biogenesis and alterations of mitochondrial antioxidant defense in Friedreich's ataxia

  2011cites this paper
• Isolation and characterization of a subset of erythropoietin glycoforms with cytoprotective but minimal erythropoietic activity

  2011cites this paper
• Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

  2011cites this paper
• Enhanced Delivery of Erythropoietin Across the Blood–Brain Barrier for Neuroprotection Against Ischemic Neuronal Injury

  2010cites this paper
• 10 – Modulation of Immune Response by Head Injury

  2010cites this paper
• Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research.

  2010cites this paper
• Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?

  2010cites this paper
• Neuroprotective effects of erythropoietin during deep hypothermic circulatory arrest.

  2010cites this paper
• Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury.

  2010cites this paper
• Exploring New Routes for Neuroprotective Drug Development in Traumatic Brain Injury

  2010cites this paper
• Erythropoietin and soluble CD44 levels in patients with primary open‐angle glaucoma

  2010cites this paper
• The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke.

  2010influential citation
• Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor.

  2010cites this paper
• Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men.

  2010influential citation
• Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.

  2009cites this paper
• Can we improve neurological outcomes in severe traumatic brain injury? Something old (early prophylactic hypothermia) and something new (erythropoietin).

  2009cites this paper
• Erythropoietin Improved Neurologic Outcomes in Newborns With Hypoxic-Ischemic Encephalopathy

  2009cites this paper
• Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection

  2009cites this paper
• Friedreich’s Ataxia: From the (GAA)n Repeat Mediated Silencing to New Promising Molecules for Therapy

  2009cites this paper
• The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer

  2009cites this paper
• Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse.

  2009cites this paper
• The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery

  2009cites this paper
• Pharmacokinetics of erythropoiesis-stimulating agents

  2009cites this paper
• An Approach to Using Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants

  2008cites this paper
• Urinary loss of erythropoietin after intravenous versus subcutaneous epoetin-beta in preterm infants.

  2008cites this paper
• Recombinant Human Erythropoietin Increases Frataxin Protein Expression Without Increasing mRNA Expression

  2008cites this paper
• Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis

  2008influential citation
• Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model.

  2008cites this paper
• Characterization of the Pharmacokinetics of Human Recombinant Erythropoietin in Blood and Brain When Administered Immediately after Lateral Fluid Percussion Brain Injury and Its Pharmacodynamic Effects on IL-1β and MIP-2 in Rats

  2008cites this paper
• The non‐haematopoietic biological effects of erythropoietin

  2008cites this paper
• Survival and proliferative roles of erythropoietin beyond the erythroid lineage

  2008cites this paper
• Old friends in new constellations--the hematopoetic growth factors G-CSF, GM-CSF, and EPO for the treatment of neurological diseases.

  2008cites this paper
• Erythropoietin‐mediated tissue protection: reducing collateral damage from the primary injury response

  2008cites this paper
• Effects of erythropoietin and lithium on neural precursors and blood -derived cells

  2008cites this paper
• Quantitative EEG findings in patients with chronic renal failure.

  2007cites this paper
• Modulation of immune response by head injury.

  2007cites this paper
• Erythropoietin and ischemic conditioning – why two good things may be bad

  2007cites this paper
• Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature

  2007cites this paper
• Small molecules affecting transcription in Friedreich ataxia.

  2007cites this paper
• Role of erythropoietin in the brain.

  2007cites this paper